GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
2,464.40
-31.00 (-1.24%)
Oct 21, 2026, 3:29 PM IST
NSE:GLAXO Market Cap
NSE:GLAXO has a market cap or net worth of 417.37 billion as of October 21, 2026. Its market cap has decreased by 10.26% in one year.
Market Cap
417.37B
Enterprise Value
390.14B
Revenue
39.55B
Global Rank
n/a
Country Rank
n/a
PE Ratio
39.08
ChartMarket Cap Chart
Since October 25, 2001, NSE:GLAXO's market cap has increased from 19.14B to 417.37B, an increase of 2,080.63%. That is a compound annual growth rate of 13.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 417.37B | -0.29% |
| Dec 31, 2025 | 418.59B | 9.72% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 239.77B |
| Pfizer | 171.77B |
| Marksans Pharma | 135.11B |
| CORONA Remedies | 123.60B |
| Sanofi Consumer Healthcare India | 77.31B |
| Senores Pharmaceuticals | 56.37B |
| SMS Pharmaceuticals | 40.67B |
| Sai Parenteral's | 20.66B |